2025. Ocular hypotensive efficacy of a new liposomal latanoprost formulation administered by different routes for experimental ocular hypertension. Ukrainian Journal of Ophthalmology . 2 (Aug. 2025), 37–41. DOI:https://doi.org/10.31288/oftalmolzh202223741.